PRP is Not Recommended for ATFL Ankle Ligament Tears
Based on the highest-quality guideline evidence, PRP injections should not be used for anterior talofibular ligament (ATFL) tears, as they have been shown to be no better than placebo for pain and functional outcomes 1.
Primary Evidence from Guidelines
The 2018 British Journal of Sports Medicine guideline on ankle sprains explicitly states that platelet-rich plasma injections were not superior for pain and functional outcomes compared with placebo injections (level 3 evidence) 1. This guideline represents the most authoritative and recent consensus on ankle sprain management.
The 2019 AAOS/NIH consensus further reinforces caution around biologics, emphasizing that clinical use of PRP has "greatly outpaced the evidence" and expressing concern about "misinformation from direct-to-consumer marketing of largely unproven biologic treatments" 2. This consensus specifically calls for minimum standards for product characterization and clinical research before widespread adoption.
What Actually Works for ATFL Tears
Instead of PRP, the evidence strongly supports:
- Functional support (ankle brace) for 4-6 weeks - shows the greatest effects compared to other treatments 1
- Early exercise therapy - reduces recurrent injuries, reduces functional ankle instability, and speeds recovery 1
- Short-term immobilization (<10 days) followed by functional support can decrease pain and edema 1
Addressing the Conflicting Research Evidence
While one 2022 study 3 suggested PRP might help with early symptom relief in grade II lateral ankle sprains, this finding has critical limitations:
- The study showed all groups had similar outcomes by 6 months - meaning any early benefit disappeared 3
- This contradicts the guideline-level evidence showing no superiority over placebo 1
- The study was not placebo-controlled and had a small sample size (n=83)
A 2026 systematic review specifically examining PRP for lateral ankle ligament injuries found "no consistent differences in clinical outcome scores between PRP and control cohorts" and concluded the evidence is "insufficient to determine whether PRP provides any clinical advantage over standard care" 4.
Clinical Bottom Line
Do not offer PRP for ATFL tears. Instead, prescribe an ankle brace for 4-6 weeks combined with early exercise therapy focusing on neuromuscular and proprioceptive training. This approach has level 1 and 2 evidence for reducing recurrent injuries and improving functional outcomes 1.
Common Pitfalls to Avoid
- Patient pressure from direct-to-consumer marketing - Be prepared to explain that PRP is unproven and not superior to placebo for this indication
- Confusing ACL evidence with ankle ligament evidence - Some studies show potential PRP benefits for ACL injuries 5, 6, 7, but this does not translate to ankle ligaments
- Assuming "biologic" means "better" - The term carries marketing appeal but lacks evidence support for ATFL injuries